✦ LIBER ✦
399 Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: Is dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than high dose chemotherapy (HDCT) with peripheral stem cell transplantation (PSCT)?
✍ Scribed by P. Kellokumpu-Lehtinen
- Book ID
- 118620573
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 160 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.